Utilizing Liposomes That Selectively Target Inflamed Endothelium to Upregulate Macrophage-Like Cell ABCA1 Through Endothelial Cell-Derived Exosome-Mediated Processes
Frontiers in Bioscience-Landmark · 10.10.2026 · 31 (10)
DOI: 10.31083/fbl54786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 10.10.2026. Verfasst von Saphala Dhital und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food, Nutrition, and Packaging Sciences, Clemson University, Clemson, SC 29634, USA. Hauptthemen laut MEDLINE: Exosomes, ATP Binding Cassette Transporter 1, Macrophages, Liposomes. Die Arbeit nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH/NHLBI R15 Academic Research Enhancement Award (AREA), USDA/NIFA-Hatch Project.
Abstract (Originalsprache)
Background
Atherosclerosis is caused by lipid accumulation in arterial endothelial cells and intimal cells. Atherosclerosis generally occurs in arteries that exhibit vascular inflammation, thereby making pro-inflammatory arterial endothelial cells a potential target for delivering atheroprotective material. Lipid-laden macrophages and vascular smooth muscle cells that have transdifferentiated into macrophage-like cells from cholesterol accumulation are the two primary intimal cell types that drive atherosclerosis. We have constructed a novel liposome-based therapeutic system (LP-pXMoA5p) that can specifically target inflamed arterial endothelial cells, resulting in endothelial cells that internalize LP-pXMoA5p to express and then package anti-miR-33a-5p into exosomes that are released basolaterally, which may lead to effective transfer of atheroprotective anti-miR-33a-5p to intimal cells. We have previously tested this delivery method with cultured macrophages being the recipient of endothelial-cell-derived exosomes filled with anti-miR-33a-5p, resulting in enhanced macrophage ABCA1-dependent cholesterol efflux.
Methods
In this study, we wanted to test whether our LP-pXMoA5p delivery system is successful when utilizing cultured macrophage-like cells as the recipient cells for endothelial-cell-derived exosomes loaded with anti-miR-33a-5p. To test the atheroprotective efficacy of our LP-pXMoA5p delivery method, we measured miR-33a-5p expression, ABCA1 protein expression, and apoAI-mediated cholesterol efflux in recipient macrophage-like cells.
Results
In our experiments, we observed that cultured macrophage-like cells incubated with anti-miR-33a-5p-filled exosomes exhibited high levels of cellular anti-miR-33a-5p, which resulted in decreased miR-33a-5p expression. Moreover, inhibition of miR-33a-5p within macrophage-like cells caused enhanced apoAI-mediated cholesterol efflux in these cells, which was likely the result of increased ABCA1 protein expression.
Conclusions
Our findings reveal that LP-pXMoA5p appears capable of enhancing ABCA1-dependent cholesterol efflux within cultured macrophage-like cells, with this outcome potentially being due to macrophage-like cells internalizing anti-miR-33a-5p-loaded exosomes which are secreted by pro-inflammatory cultured immortalized mouse aortic endothelial cells (iMAECs), but we acknowledge this may not translate to similar effects in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food, Nutrition, and Packaging Sciences, Clemson University, Clemson, SC 29634, USA.
- Department of Bioengineering, Clemson University, Clemson, SC 29634, USA.
- Clemson Light Imaging Facility, Clemson University, Clemson, SC 29634, USA.
- Department of Obstetrics & Gynecology, University of Washington, Seattle, WA 98109, USA.
- Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30322, USA.
- School of Health and Human Sciences, South Dakota State University, Brookings, SD 57007, USA.
Förderung
- NIH/NHLBI R15 Academic Research Enhancement Award (AREA)
- USDA/NIFA-Hatch Project
Zitieren
APA
Dhital, S., Echesabal-Chen, J., Pokhrel, A., Brawner, A., Huang, K., Powell, R. R., Bruce, T., Vojtech, L., Jo, H., & Stamatikos, A. (2026). Utilizing Liposomes That Selectively Target Inflamed Endothelium to Upregulate Macrophage-Like Cell ABCA1 Through Endothelial Cell-Derived Exosome-Mediated Processes. Frontiers in Bioscience-Landmark, 31(10). https://doi.org/10.31083/fbl54786
Vancouver
Dhital S, Echesabal-Chen J, Pokhrel A, Brawner A, Huang K, Powell RR, et al. Utilizing Liposomes That Selectively Target Inflamed Endothelium to Upregulate Macrophage-Like Cell ABCA1 Through Endothelial Cell-Derived Exosome-Mediated Processes. Frontiers in Bioscience-Landmark. 2026;31(10). doi:10.31083/fbl54786
BibTeX
@article{Dhital2026,
author = {Dhital, Saphala and Echesabal-Chen, Jing and Pokhrel, Achala and Brawner, Ally and Huang, Kun and Powell, Rhonda R and Bruce, Terri and Vojtech, Lucia and Jo, Hanjoong and Stamatikos, Alexis},
title = {Utilizing Liposomes That Selectively Target Inflamed Endothelium to Upregulate Macrophage-Like Cell ABCA1 Through Endothelial Cell-Derived Exosome-Mediated Processes},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {10},
doi = {10.31083/fbl54786}
}
EUVIMED